JP7103752B2 - 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤 - Google Patents

疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤 Download PDF

Info

Publication number
JP7103752B2
JP7103752B2 JP2017026907A JP2017026907A JP7103752B2 JP 7103752 B2 JP7103752 B2 JP 7103752B2 JP 2017026907 A JP2017026907 A JP 2017026907A JP 2017026907 A JP2017026907 A JP 2017026907A JP 7103752 B2 JP7103752 B2 JP 7103752B2
Authority
JP
Japan
Prior art keywords
strontium
pain
calcium
pruritus
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017026907A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018027929A (ja
JP2018027929A5 (https=
Inventor
エス． ハーン ゲイリー
グディ シヴァ
Original Assignee
コスメダーム バイオサイエンス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コスメダーム バイオサイエンス， インコーポレイテッド filed Critical コスメダーム バイオサイエンス， インコーポレイテッド
Publication of JP2018027929A publication Critical patent/JP2018027929A/ja
Publication of JP2018027929A5 publication Critical patent/JP2018027929A5/ja
Priority to JP2021087003A priority Critical patent/JP7322094B2/ja
Application granted granted Critical
Publication of JP7103752B2 publication Critical patent/JP7103752B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017026907A 2015-08-21 2017-02-16 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤 Active JP7103752B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021087003A JP7322094B2 (ja) 2015-08-21 2021-05-24 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562208249P 2015-08-21 2015-08-21
US15/239,171 US20170049807A1 (en) 2015-08-21 2016-08-17 Strontium based compositions and formulations for pain, pruritus, and inflammation
US15/239,171 2016-08-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021087003A Division JP7322094B2 (ja) 2015-08-21 2021-05-24 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤

Publications (3)

Publication Number Publication Date
JP2018027929A JP2018027929A (ja) 2018-02-22
JP2018027929A5 JP2018027929A5 (https=) 2020-03-05
JP7103752B2 true JP7103752B2 (ja) 2022-07-20

Family

ID=58157450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017026907A Active JP7103752B2 (ja) 2015-08-21 2017-02-16 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
JP2021087003A Active JP7322094B2 (ja) 2015-08-21 2021-05-24 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021087003A Active JP7322094B2 (ja) 2015-08-21 2021-05-24 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤

Country Status (4)

Country Link
US (1) US20170049807A1 (https=)
JP (2) JP7103752B2 (https=)
AU (2) AU2017201085B2 (https=)
ES (1) ES2925861T3 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3172684B2 (ja) 1996-12-03 2001-06-04 ワイケイケイアーキテクチュラルプロダクツ株式会社 断熱サッシ

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2827847B1 (en) 2012-03-21 2022-09-14 Galleon Labs LLC Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
US11235002B2 (en) 2015-08-21 2022-02-01 Galleon Labs Llc Strontium based compositions and formulations for pain, pruritus, and inflammation
US20210113496A1 (en) * 2018-04-25 2021-04-22 Horizon Orphan Llc Methods of Treating Excitotoxicity Disorders
WO2022173813A1 (en) * 2021-02-09 2022-08-18 The Regents Of The University Of California Improved bhb-citrate formulations for promoting health
CN113041487B (zh) * 2021-04-23 2025-01-28 佳木斯大学 一种90锶敷贴器治疗装置
CN114452297B (zh) * 2021-12-30 2024-03-12 河南大新药业有限公司 一种治疗皮炎的药物制剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509366A (ja) 1999-09-14 2003-03-11 テファ， インコーポレイテッド γ−ヒドロキシブチレートを含むポリマーおよびオリゴマーの治療的用途
JP2005507396A (ja) 2001-09-28 2005-03-17 サントソルヴ エーエス 真皮下軟組織の痛みの治療のためのストロンチウム化合物
JP2015510943A (ja) 2012-03-21 2015-04-13 コスメダーム バイオサイエンス， インコーポレイテッド 疼痛、そう痒および炎症を処置するために局所的に投与されるストロンチウム含有複合体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051609A (en) * 1997-09-09 2000-04-18 Tristrata Technology, Inc. Additives enhancing the effect of therapeutic agents
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509366A (ja) 1999-09-14 2003-03-11 テファ， インコーポレイテッド γ−ヒドロキシブチレートを含むポリマーおよびオリゴマーの治療的用途
JP2005507396A (ja) 2001-09-28 2005-03-17 サントソルヴ エーエス 真皮下軟組織の痛みの治療のためのストロンチウム化合物
JP2015510943A (ja) 2012-03-21 2015-04-13 コスメダーム バイオサイエンス， インコーポレイテッド 疼痛、そう痒および炎症を処置するために局所的に投与されるストロンチウム含有複合体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3172684B2 (ja) 1996-12-03 2001-06-04 ワイケイケイアーキテクチュラルプロダクツ株式会社 断熱サッシ

Also Published As

Publication number Publication date
AU2017201085A1 (en) 2018-03-08
JP2021119208A (ja) 2021-08-12
ES2925861T3 (es) 2022-10-20
AU2023222925B2 (en) 2025-06-12
BR102017003561A2 (pt) 2018-03-06
JP2018027929A (ja) 2018-02-22
AU2023222925A1 (en) 2023-09-21
JP7322094B2 (ja) 2023-08-07
US20170049807A1 (en) 2017-02-23
AU2017201085B2 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
JP7322094B2 (ja) 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
US11801261B2 (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
WO2016141219A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US20250099498A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
US9480704B2 (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
US20170157169A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
WO2020132195A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
CA2958169C (en) Strontium-based compositions and formulations for pain, itching, and inflammation
BR102017003561B1 (pt) Composições a base de estrôncio e formulações para dor, prurido e inflamação

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220126

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220707

R150 Certificate of patent or registration of utility model

Ref document number: 7103752

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250